|
Q1 2024
|
27 |
115,263 |
AL, EPD, NVGS, BL
|
13F-HR
|
5/13/2024 |
000101905624000167 |
|
Q4 2023
|
26 |
114,479 |
AL, NVGS, EPD, FIVN
|
13F-HR
|
2/14/2024 |
000101905624000094 |
|
Q3 2023
|
28 |
119,536 |
AL, NVGS, EPD, ETWO
|
13F-HR
|
11/14/2023 |
000101905623000395 |
|
Q2 2023
|
29 |
149,441 |
NVGS, AL, ETWO, NEWR
|
13F-HR
|
8/8/2023 |
000101905623000330 |
|
Q1 2023
|
28 |
148,971 |
NVGS, AL, NEWR, ETWO
|
13F-HR
|
4/10/2023 |
000101905623000203 |
|
Q4 2022
|
29 |
148,156 |
APEN, NVGS, AL, EPD
|
13F-HR
|
2/7/2023 |
000101905623000102 |
|
Q3 2022
|
32 |
154,430 |
NVGS, AMRC, PCRX, EPD
|
13F-HR
|
11/14/2022 |
000101905622000643 |
|
Q2 2022
|
33 |
165,106 |
PCRX, NVGS, AL, EPD
|
13F-HR
|
8/1/2022 |
000101905622000524 |
|
Q1 2022
|
33 |
217,085 |
PCRX, AMRC, AL, NVGS
|
13F-HR
|
5/9/2022 |
000101905622000376 |
|
Q4 2021
|
34 |
251,749 |
AOSL, PCRX, AMRC, NEWR
|
13F-HR
|
2/8/2022 |
000101905622000152 |
|
Q3 2021
|
35 |
252,105 |
CDNA, BL, AMRC, AOSL
|
13F-HR
|
11/12/2021 |
000101905621000589 |
|
Q2 2021
|
32 |
263,102 |
CDNA, AMRC, BL, FIVN
|
13F-HR
|
7/28/2021 |
000101905621000435 |
|
Q1 2021
|
30 |
242,888 |
CDNA, AMRC, AOSL, PCRX
|
RESTATEMENT
|
7/28/2021 |
000101905621000433 |
|
Q4 2020
|
29 |
222,461 |
CDNA, AMRC, BL, FIVN
|
13F-HR
|
2/12/2021 |
000101905621000106 |
|
Q3 2020
|
30 |
162,906 |
AMRC, CDNA, PCRX, BL
|
13F-HR
|
11/12/2020 |
000101905620000562 |
|
Q2 2020
|
26 |
138,944 |
AMRC, CDNA, BL, PCRX
|
RESTATEMENT
|
8/14/2020 |
000101905620000481 |
|
Q1 2020
|
27 |
107,167 |
AMRC, CDNA, BL, PCRX
|
13F-HR
|
5/11/2020 |
000101905620000312 |
|
Q4 2019
|
32 |
178,379 |
AL, AMRC, GFN, EVBG
|
13F-HR
|
2/14/2020 |
000101905620000154 |
|
Q3 2019
|
32 |
161,282 |
AL, AMRC, EQIX, GFN
|
13F-HR
|
11/8/2019 |
000101905619000635 |
|
Q2 2019
|
33 |
175,183 |
EVBG, CDNA, AL, AMRC
|
13F-HR
|
8/12/2019 |
000101905619000467 |
|
Q1 2019
|
33 |
174,791 |
CDNA, AMRC, EVBG, AL
|
13F-HR
|
5/13/2019 |
000101905619000285 |
|
Q4 2018
|
31 |
142,288 |
CDNA, RHT, GFN, AMRC
|
13F-HR
|
1/18/2019 |
000101905619000020 |
|
Q3 2018
|
30 |
166,888 |
CDNA, GFN, RHT, AMRC
|
13F-HR
|
11/13/2018 |
000101905618001064 |
|
Q2 2018
|
29 |
157,967 |
GFN, CDNA, RHT, NEWR
|
13F-HR
|
8/9/2018 |
000101905618000940 |
|
Q1 2018
|
31 |
134,384 |
GFN, RHT, AL, AMRC
|
13F-HR
|
5/9/2018 |
000101905618000595 |
|
Q4 2017
|
30 |
136,423 |
GFN, AL, FIVN, RHT
|
13F-HR
|
2/13/2018 |
000101905618000330 |
|
Q3 2017
|
29 |
131,961 |
GFN, FIVN, AL, RTEC
|
13F-HR
|
11/14/2017 |
000101905617000763 |
|
Q2 2017
|
27 |
115,944 |
GFN, AL, RHT, AMRC
|
13F-HR
|
7/20/2017 |
000101905617000610 |
|
Q1 2017
|
27 |
109,848 |
AL, GFN, LL, RHT
|
13F-HR
|
5/11/2017 |
000101905617000445 |
|
Q4 2016
|
27 |
121,014 |
AL, GFN, RTEC, RHT
|
13F-HR
|
2/14/2017 |
000101905617000185 |
|
Q3 2016
|
28 |
126,648 |
RTEC, AL, AOSL, RHT
|
13F-HR
|
11/14/2016 |
000101905616001645 |
|
Q2 2016
|
26 |
118,270 |
NVGS, RTEC, AL, RHT
|
RESTATEMENT
|
8/24/2016 |
000101905616001508 |
|
Q1 2016
|
23 |
113,370 |
AL, EQIX, RTEC, GFN
|
13F-HR
|
5/3/2016 |
000101905616001286 |
|
Q4 2015
|
23 |
135,075 |
RHT, ATHENAHEALTH INC, EQIX, AL
|
13F-HR
|
2/16/2016 |
000101905616001069 |
|
Q3 2015
|
23 |
122,917 |
RHT, EQIX, ATHENAHEALTH INC, AL
|
13F-HR
|
10/16/2015 |
000101905615000815 |
|
Q2 2015
|
23 |
146,059 |
RHT, EQIX, AL, GFN
|
13F-HR
|
7/24/2015 |
000101905615000635 |
|
Q1 2015
|
24 |
170,602 |
GFN, RHT, EQIX, NVCN
|
13F-HR
|
5/12/2015 |
000101905615000479 |
|
Q4 2014
|
23 |
166,116 |
GFN, EQIX, RHT, ATHENAHEALTH INC
|
13F-HR
|
2/13/2015 |
000101905615000172 |
|
Q3 2014
|
26 |
161,755 |
GFN, NVCN, EQIX, ATHENAHEALTH INC
|
13F-HR
|
10/15/2014 |
000101905614001317 |
|
Q2 2014
|
24 |
159,969 |
GFN, NVCN, AL, EQIX
|
13F-HR
|
7/31/2014 |
000101905614000980 |
|
Q1 2014
|
28 |
176,537 |
NVCN, GFN, AL, ATHENAHEALTH INC
|
13F-HR
|
5/6/2014 |
000101905614000635 |
|
Q4 2013
|
28 |
172,838 |
NOVADAQ TECHNOLOGIES INC COMMON, GFN, NVCN, ATHENAHEALTH INC
|
13F-HR
|
2/6/2014 |
000101905614000139 |